CellSource Co., Ltd. provided non-consolidated earnings guidance for the fiscal year ending October 31, 2023. Net sales to be JPY 5,192 million, operating profit to be JPY 1,625 million, profit to be JPY 1,024 million and basic earnings per share to be JPY 54.81 per share.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,191 JPY | +2.94% | -3.88% | -6.96% |
2023 | Certain Common Shares of Cuorips Inc. are subject to a Lock-Up Agreement Ending on 23-DEC-2023. | CI |
2023 | MEDERI Inc. announced that it has received funding from CellSource Co., Ltd. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.96% | 147M | |
-21.60% | 8.05B | |
+77.60% | 4.56B | |
+8.39% | 2.74B | |
-2.80% | 2.65B | |
-49.62% | 2.02B | |
-13.10% | 1.8B | |
-20.79% | 1.46B | |
+16.24% | 1.2B | |
-44.65% | 1.13B |
- Stock Market
- Equities
- 4880 Stock
- News CellSource Co., Ltd.
- Cellsource Co., Ltd. Provides Non-Consolidated Earnings Guidance for the Fiscal Year Ending October 31, 2023